These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

332 related articles for article (PubMed ID: 29376427)

  • 1. [The role of apolipoprotein M and sphingosine 1-phosphate axis in the prevention of atherosclerosis].
    Nádró B; Juhász L; Szentpéteri A; Páll D; Paragh G; Harangi M
    Orv Hetil; 2018 Feb; 159(5):168-175. PubMed ID: 29376427
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sphingosine 1-Phosphate and Atherosclerosis.
    Kurano M; Yatomi Y
    J Atheroscler Thromb; 2018 Jan; 25(1):16-26. PubMed ID: 28724841
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High-Density Lipoprotein-Associated Apolipoprotein M Limits Endothelial Inflammation by Delivering Sphingosine-1-Phosphate to the Sphingosine-1-Phosphate Receptor 1.
    Ruiz M; Frej C; Holmér A; Guo LJ; Tran S; Dahlbäck B
    Arterioscler Thromb Vasc Biol; 2017 Jan; 37(1):118-129. PubMed ID: 27879252
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hepatic apolipoprotein M (apoM) overexpression stimulates formation of larger apoM/sphingosine 1-phosphate-enriched plasma high density lipoprotein.
    Liu M; Seo J; Allegood J; Bi X; Zhu X; Boudyguina E; Gebre AK; Avni D; Shah D; Sorci-Thomas MG; Thomas MJ; Shelness GS; Spiegel S; Parks JS
    J Biol Chem; 2014 Jan; 289(5):2801-14. PubMed ID: 24318881
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Apolipoprotein M mediates sphingosine-1-phosphate efflux from erythrocytes.
    Christensen PM; Bosteen MH; Hajny S; Nielsen LB; Christoffersen C
    Sci Rep; 2017 Nov; 7(1):14983. PubMed ID: 29118354
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High-density lipoprotein from end-stage renal disease patients exhibits superior cardioprotection and increase in sphingosine-1-phosphate.
    Brinck JW; Thomas A; Brulhart-Meynet MC; Lauer E; Frej C; Dahlbäck B; Stenvinkel P; James RW; Frias MA
    Eur J Clin Invest; 2018 Feb; 48(2):. PubMed ID: 29178180
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Apolipoprotein M modulates erythrocyte efflux and tubular reabsorption of sphingosine-1-phosphate.
    Sutter I; Park R; Othman A; Rohrer L; Hornemann T; Stoffel M; Devuyst O; von Eckardstein A
    J Lipid Res; 2014 Aug; 55(8):1730-7. PubMed ID: 24950692
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Liver involvement in sphingosine 1-phosphate dynamism revealed by adenoviral hepatic overexpression of apolipoprotein M.
    Kurano M; Tsukamoto K; Ohkawa R; Hara M; Iino J; Kageyama Y; Ikeda H; Yatomi Y
    Atherosclerosis; 2013 Jul; 229(1):102-9. PubMed ID: 23664237
    [TBL] [Abstract][Full Text] [Related]  

  • 9. HDL-associated ApoM is anti-apoptotic by delivering sphingosine 1-phosphate to S1P1 & S1P3 receptors on vascular endothelium.
    Ruiz M; Okada H; Dahlbäck B
    Lipids Health Dis; 2017 Feb; 16(1):36. PubMed ID: 28179022
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Glycation of HDL Polymerizes Apolipoprotein M and Attenuates Its Capacity to Bind to Sphingosine 1-Phosphate.
    Kobayashi T; Kurano M; Nanya M; Shimizu T; Ohkawa R; Tozuka M; Yatomi Y
    J Atheroscler Thromb; 2021 Jul; 28(7):730-741. PubMed ID: 32999208
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Plasma levels of sphingosine-1-phosphate and apolipoprotein M in patients with monogenic disorders of HDL metabolism.
    Karuna R; Park R; Othman A; Holleboom AG; Motazacker MM; Sutter I; Kuivenhoven JA; Rohrer L; Matile H; Hornemann T; Stoffel M; Rentsch KM; von Eckardstein A
    Atherosclerosis; 2011 Dec; 219(2):855-63. PubMed ID: 21944699
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Regulation of the apolipoprotein M signaling pathway: a review.
    Cheng G; Zheng L
    J Recept Signal Transduct Res; 2022 Jun; 42(3):285-292. PubMed ID: 34006168
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sphingosine 1-phosphate and its carrier apolipoprotein M in human sepsis and in Escherichia coli sepsis in baboons.
    Frej C; Linder A; Happonen KE; Taylor FB; Lupu F; Dahlbäck B
    J Cell Mol Med; 2016 Jun; 20(6):1170-81. PubMed ID: 26990127
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sphingosine-1-phosphate: metabolism, transport, atheroprotection and effect of statin treatment.
    Therond P; Chapman MJ
    Curr Opin Lipidol; 2022 Jun; 33(3):199-207. PubMed ID: 35695616
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of apolipoprotein M in uremic atherosclerosis.
    Bosteen MH; Madsen Svarrer EM; Bisgaard LS; Martinussen T; Madsen M; Nielsen LB; Christoffersen C; Pedersen TX
    Atherosclerosis; 2017 Oct; 265():93-101. PubMed ID: 28866363
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dihydro-sphingosine 1-phosphate interacts with carrier proteins in a manner distinct from that of sphingosine 1-phosphate.
    Mishima Y; Kurano M; Kobayashi T; Nishikawa M; Ohkawa R; Tozuka M; Yatomi Y
    Biosci Rep; 2018 Oct; 38(5):. PubMed ID: 30279204
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Uncleaved ApoM signal peptide is required for formation of large ApoM/sphingosine 1-phosphate (S1P)-enriched HDL particles.
    Liu M; Allegood J; Zhu X; Seo J; Gebre AK; Boudyguina E; Cheng D; Chuang CC; Shelness GS; Spiegel S; Parks JS
    J Biol Chem; 2015 Mar; 290(12):7861-70. PubMed ID: 25627684
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Involvement of CETP (Cholesteryl Ester Transfer Protein) in the Shift of Sphingosine-1-Phosphate Among Lipoproteins and in the Modulation of its Functions.
    Kurano M; Hara M; Ikeda H; Tsukamoto K; Yatomi Y
    Arterioscler Thromb Vasc Biol; 2017 Mar; 37(3):506-514. PubMed ID: 28126827
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Regulation of the metabolism of apolipoprotein M and sphingosine 1-phosphate by hepatic PPARγ activity.
    Kurano M; Ikeda H; Iso-O N; Hara M; Tsukamoto K; Yatomi Y
    Biochem J; 2018 Jun; 475(12):2009-2024. PubMed ID: 29712716
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A Shift in ApoM/S1P Between HDL-Particles in Women With Type 1 Diabetes Mellitus Is Associated With Impaired Anti-Inflammatory Effects of the ApoM/S1P Complex.
    Frej C; Mendez AJ; Ruiz M; Castillo M; Hughes TA; Dahlbäck B; Goldberg RB
    Arterioscler Thromb Vasc Biol; 2017 Jun; 37(6):1194-1205. PubMed ID: 28385702
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.